A panel of F.D.A. advisers is meeting about Merck’s Covid pill.. Molnupiravir (Drug), Coronavirus (2019-nCoV), Merck & Company Inc, Food and Drug Administration, Coronavirus Omicron Variant, Vaccination and Immunization